Clinical Trials Logo

Filter by:
NCT ID: NCT05962398 Enrolling by invitation - Hemophilia B Clinical Trials

Long-term Follow-up Study of Male Adults With Hemophilia B Previously Treated With Etranacogene Dezaparvovec (CSL222)

Start date: August 30, 2023
Phase:
Study type: Observational

The primary purpose of this study is to assess the long-term safety in male adults with hemophilia B who were treated with CSL222 in studies CSL222_2001 (NCT03489291) or CSL222_3001 (NCT03569891).

NCT ID: NCT05962346 Enrolling by invitation - Clinical trials for Congenital Diaphragmatic Hernia

Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

FETO
Start date: May 2025
Phase: N/A
Study type: Interventional

The purpose of this research is to gather information on the safety and effectiveness of a procedure called Fetoscopic Endoluminal Tracheal Occlusion (FETO) at Mayo Clinic. The intent of the FETO procedure is to improve development of the lungs in fetuses diagnosed with severe congenital diaphragmatic hernia (CDH).

NCT ID: NCT05959031 Enrolling by invitation - Healthy Clinical Trials

Parameter Space of kTMP

SBIR_2022
Start date: August 16, 2022
Phase: N/A
Study type: Interventional

The investigators have recently developed a new non-invasive brain stimulation (NIBS) system, kilohertz transcranial magnetic perturbation (kTMP) that opens up a new experimental space for safely modulating neural excitability in targeted areas of the human brain. This project will characterize the broad parameter space of kTMP in terms of tolerability and efficacy in healthy individuals. Following earlier feasibility studies, we are now increasing our number of subjects in order to capture preliminary safety and effectiveness information on a near-final device.

NCT ID: NCT05957913 Enrolling by invitation - Multiple Sclerosis Clinical Trials

Effects of Antiviral Therapies on Epstein-Barr Virus Replication

Start date: June 5, 2023
Phase: Phase 2
Study type: Interventional

This research study is being performed to find out if Truvada (tenofovir/emtricitabine), an antiviral drug with activity against the Epstein Barr virus (EBV), can reduce EBV levels in saliva and blood in people with multiple sclerosis (MS). A second goal is to find out if Truvada (tenofovir/ emtricitabine) is safe and tolerable in people with MS.

NCT ID: NCT05956535 Enrolling by invitation - Corneal Edema Clinical Trials

Air Optix® Night and Day® Aqua Therapeutic Wear

Start date: September 26, 2023
Phase:
Study type: Observational

The purpose of this study is to support the safety and performance assessment of Air Optix Night and Day Aqua (AONDA) soft contact lenses for therapeutic use in accordance with updated EU Medical Device Regulation (MDR) requirements.

NCT ID: NCT05955898 Enrolling by invitation - Mental Health Issue Clinical Trials

The Development and Evaluation of a Single Session Intervention for Parent Distress Tolerance

Start date: May 17, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to study different ways to help parents cope with strong emotions. The study team will be looking at how two different treatments help parents learn to manage strong emotions. These treatments are one session and are completed online, without a therapist, like an online training or class.

NCT ID: NCT05954273 Enrolling by invitation - Clinical trials for Sinus Floor Augmentation

Maxillary Sinus Membrane Perforation Incidence During Osseodensification

Start date: April 3, 2023
Phase:
Study type: Observational

Measure the incidence of the maxillary sinus membrane perforation during the Osseodensification crestal sinus grafting procedure.

NCT ID: NCT05952999 Enrolling by invitation - Hypertension Clinical Trials

Analysis of the Virtual Acute Care at Home Experience

HaH
Start date: August 15, 2023
Phase:
Study type: Observational

The purpose of this study is to examine the implementation, intervention effectiveness, and dissemination of a digital acute care delivery model for improving selected health outcomes in the Hospital at Home population.

NCT ID: NCT05952401 Enrolling by invitation - Smoking Cessation Clinical Trials

Implementation Science to Reduce the Disparity in Tobacco Treatment Among Individuals With Serious Mental Illness

ISRAISE
Start date: May 31, 2024
Phase: N/A
Study type: Interventional

This is a pilot trial to examine the feasibility and preliminary effect of a multilevel intervention 'Nudges to Quit' on smoking cessation in patients with serious mental illness who smoke in a community mental health center (CMHC). "Nudges to Quit" is a multilevel intervention to increate engagement of patient, case worker, and pharmacist with tobacco treatment. The pilot trial is to generate the needed evidence for designing a future large trial to evaluate the effect of 'Nudges to Quit' as a multilevel intervention to increase tobacco treatment and reduce tobacco use among patients with serious mental illness.

NCT ID: NCT05950724 Enrolling by invitation - Clinical trials for Lung Transplant; Complications

RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant

Start date: September 17, 2023
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to assess whether TNFa antibody use before lung transplant can prevent kidney injury after lung transplant.